Moderna, Pfizer hit with new patent lawsuits over COVID vaccines

aol.com Biotech firm Promosome LLC sued Moderna, Pfizer and BioNTech in federal court in San Diego, California, on Tuesday, accusing their COVID-19 vaccines of infringing a patent…

Is Frontline's 20% Dividend Too Good To Be True?

marketbeat.com The Cyprus-based tanker firm Frontline NYSE: FRO, on May 31, posted stellar earnings of $0.90 per share and declared a $0.70 dividend. Given the company's stock price of…

Granite Digital expands to the US with LCM247 deal

siliconrepublic.com Granite Digital expects to boost its revenue by $3m over the next 18 months and has gained a strategic foothold in the US through this deal. Irish digital agency Granite…

Cancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna data

ksl.com CHICAGO — An experimental mRNA-based vaccine from Moderna and Merck reduced the risk that the most deadly skin cancer would spread, by 65%, compared to immunotherapy…

Michael Brush: Biotech stocks could soon get a M&A boost. Here are 3 likely takeover plays

marketwatch.com A big part of investing in biotech is owning takeover names. The quick gains offset a lot of mistakes. Having a biotech stock get bought out simplifies the “sell” decision,…

Novavax Partners With Gates Foundation Offshoot In Efforts To Develop Malaria And TB Shots

forbes.com American vaccine maker Novavax on Monday announced plans to share its powerful vaccine technology with the Bill & Melinda Gates Medical Research Institute, a nonprofit…

Repeated COVID-19 Vaccination Weakens Immune System: Study

zerohedge.com Repeated COVID-19 Vaccination Weakens Immune System: Study Authored by Zachary Stieber via The Epoch Times (emphasis ours), Repeated COVID-19 vaccination weakens the immune…

Conservatives call out multinational corporations for supporting pride month in America, but not Middle East

foxbusiness.com Conservatives on Twitter are calling out several multinational corporations for showing their support for pride month in America, but not in regions such as the Middle East.…

America needs a jab in its corporate backside

economist.com W recently visited New York, it was at its springtime best. There were cherry blossoms in Central Park, birdsong in the bushes, and—to drown out any false sense of…

Big pharma’s patent cliff is fast approaching

economist.com A of $10.8bn would look hefty for most acquisitions of smallish and newish companies. But for Merck, a drugs giant known as outside America, the money it is spending to buy…

Shareholders have high hopes for Bayer’s new boss

economist.com A , Bayer’s new boss, arrives on April 1st at the firm’s headquarters in Leverkusen, Werner Baumann, the German drug-and-chemicals giant’s outgoing chief executive, will be…

Is Novavax Stock A Sell As It Braces For A $700 Million Fight?

investors.com offered an upbeat sales outlook and announced a cost-cutting plan in mid-May, but NVAX stock has since slipped back below its 50-day line. First-quarter sales lagged…

Novartis drug cuts recurrence risk by 25% in early-stage breast cancer

reuters.com breast cancer drug Kisqali cut the risk of recurrence by more than 25% in a pivotal trial on women diagnosed at an early stage, positioning the Swiss drugmaker to win new…

Family Of College Student Who Died From COVID-19 Vaccine Sues Biden Administration

zerohedge.com Family Of College Student Who Died From COVID-19 Vaccine Sues Biden Administration Authored by Zachary Stieber via The Epoch Times (emphasis ours), The family of a college…

Navy Removes Pride Month Posts Amid Right-Wing Backlash

forbes.com Companies declaring support for Pride Month—including those that simply adopt a rainbow-colored logo for June—are facing online attacks from right-wing social media users,…

The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree

investors.com Big Pharma has a problem, and a plan to solve it. The problem? A looming drug patent cliff that will unleash generic competition on some of the industry's biggest…

BioNTech Surges On This Promising Update In Its Bid To Take On Bristol Myers In Lung Cancer Treatment

investors.com German biotechnology company BioNTech (BNTX) said Friday almost a third of patients with a hard-to-treat form of lung cancer responded to its experimental treatment — and…

What are the current trends in Ireland’s pharma sector?

siliconrepublic.com SiliconRepublic.com took a look at PDA Ireland’s Visual Inspection event to learn about Ireland’s pharma sector and its biggest strengths. Ireland’s pharmaceutical…

EU’s COVID-19 Vaccine Procurement Scandal Continues to Grow Despite Deafening Media Silence

nakedcapitalism.com “Under Commission President von der Leyen, the tendency of EU institutions (and officials) to evade their due accountability by collectively hiding behind a…

“Lessons for a Pandemic”

nakedcapitalism.com The New England Journal of Medicine has a new article, Lessons for a Pandemic, which presents itself as a high level post mortem of the US pandemic response. While it does…

Look out, GSK. Pfizer has its adult RSV vaccine approval and is raring to launch

fiercepharma.com About a month after GSK won the world's first approval for a respiratory syncytial virus (RSV) vaccine, rival Pfizer has followed suit. | After winning FDA approvals one…

Is Pfizer Stock A Buy As It Leaps Into The Red-Hot Weight-Loss Race?

investors.com stock bounded higher in mid-May on enthusiasm for its potential rival to Novo Nordisk (NVO) and Eli Lilly (LLY) in diabetes treatment and weight loss. Pfizer tested its…

FDA approves RSV vaccine for older adults

axios.com The Food and Drug Administration on Wednesday approved Pfizer's vaccine against respiratory syncytial virus for people aged 60 and older, making it the second RSV shot…

20 Best Healthcare Dividend Stocks to Invest in

marketbeat.com Investing in the healthcare sector is like having a prescription for long-term wealth. As the demand for innovative treatments, life-saving drugs and cutting-edge medical…

FDA approves Pfizer RSV vaccine for older adults

thehill.com The Food and Drug Administration (FDA) on Wednesday approved Pfizer’s vaccine to prevent the respiratory disease RSV in older adults, the company announced. After decades…

FDA Approves Pfizer’s RSV Vaccine For Older Adults

forbes.com The Food and Drug Administration on Wednesday approved Pfizer’s vaccine to protect older adults from RSV, weeks after the agency greenlit the very first shot against the…

FDA Approves Pfizer’s RSV Vaccine for Adults 60 and Older

nytimes.com Why It Matters: Older adults are at a higher risk. Each year, about 60,000 adults 65 and older are hospitalized with R.S.V. and about 6,000 to 10,000 die from the virus, the…

FDA approves Pfizer’s RSV shot for older adults, teeing up a competitive $17B vaccine market

endpts.com The FDA approved Pfizer’s RSV vaccine called Abrysvo for older adults on Wednesday, placing another Big Pharma onto the commercial stage ahead of the next RSV season.…

Project Veritas sues its founder James O'Keefe, alleging he set up a competitor and wooed donors while on the company's payroll

businessinsider.com James O'Keefe. Chip Somodevilla/Getty Images Project Veritas is suing its founder and former leader, James O'Keefe. O'Keefe set up a competitor right-wing political sting…

GSK’s CEO says you need thick skin if you’re going to step into the C-suite

fortune.com On this week’s episode of Fortune‘s Leadership Next podcast, co-hosts Alan Murray and Michal Lev-Ram talk with GSK CEO Emma Walmsley about the future of A.I. in the…

China’s commerce minister meets Tesla CEO Elon Musk, promises support to foreign companies

theglobeandmail.com China’s commerce minister met Tesla Ltd. TSLA-Q CEO Elon Musk on Wednesday and promised to support the development of foreign companies, the ministry said. Musk earlier met…

Cork-based Milestone Solutions acquired by PM Group

siliconrepublic.com PM Group plans to enhance its automation and smart manufacturing services through the Milestone acquisition. IT and automation company Milestone Solutions is being acquired…

Pfizer's Approach To Hemophilia Is 'Certainty Differentiated'

investors.com said Tuesday its experimental hemophilia treatment cut down on bleeding episodes in a pivotal study. But Pfizer stock dipped. X The drug is a under-the-skin injection…

Pfizer's hemophilia drug hits in phase 3, giving it a chance to leapfrog Novo Nordisk

fiercebiotech.com Pfizer is looming large in Novo Nordisk’s rearview mirror. | Pfizer is looming large in Novo Nordisk’s rearview mirror. Weeks after seeing its rival for the hemophilia…

2:00PM Water Cooler 5/30/2023

nakedcapitalism.com Patient readers, I’m sorry to be a little late. I got wrapped around the axle on NIH’s Long Covid study, and belatedly realized the topic really needed to be in a post. So I…

Elizabeth Holmes starts her 11-year prison sentence today. Here's what to know

npr.org Elizabeth Holmes starts her 11-year prison sentence today. Here's what to know Disgraced Silicon Valley superstar Elizabeth Holmes is set to surrender on Tuesday to begin…

Sequoia China-Backed AI Startup Xtalpi To Partner With Pharma Giant Eli Lilly In $250 Million Novel Drug Deal

forbes.com Shenzhen-based Xtalpi, an AI-powered drug discoverer, announced Tuesday it has partnered with U.S. pharmaceutical giant Eli Lilly in a deal worth up to $250 million to…

15 recent scientific breakthroughs

theweek.com Scientists in many fields have been getting little attention over the last two years or so as the world focused on the emergency push to develop vaccines and treatments for…

Eli Lilly Could Launch Its Rival To Novo Nordisk's Weight-Loss Drug A Year Earlier Than Expected

investors.com An analyst expects Eli Lilly (LLY) to launch a competitor to weight-loss drugs from Novo Nordisk (NVO) in 2026 — a year earlier than expected — giving Eli Lilly stock…

Is Novavax Stock A Buy Or A Sell As Shares Stage A Comeback On A Cost-Cutting Plan?

investors.com offered an upbeat sales outlook and announced a cost-cutting plan in mid-May, but NVAX stock has since slipped back below its 50-day line. X First-quarter sales lagged…

Is Moderna Stock A Buy After Unexpectedly Turning A First-Quarter Profit?

investors.com reported an unexpected profit in the first quarter, but Moderna stock is now trending sideways amid plummeting Covid vaccine sales. X Moderna is well on the other side of…

Americans May Not Love Crypto, But These Top Brands Are Into It

decrypt.co To paraphrase Winston Churchill, don’t listen to what they say, just watch what they do. The refrain repeatedly echoes across the mediascape: “Bitcoin is dead,” crypto is a…

Science finally figured out how to make effective RSV vaccines. Will seniors care?

statnews.com The world has waited decades for vaccines to protect older adults against RSV. One, made by GSK, was approved by the Food and Drug Administration earlier this month. A…

COVID pill Paxlovid gets full FDA approval after more than a year of emergency use

yahoo.com Pfizer received full approval on Thursday for its COVID-19 pill Paxlovid that's been the go-to treatment against the coronavirus. More than 11 million prescriptions for…

After battling COVID, can mRNA vaccines fight cancer?

pbs.org Vaccines against Covid-19 were delivered with remarkable and unprecedented speed. The ones pioneered by Moderna in the US and BioNTech in Germany introduced the lay public…

Pfizer, Moderna hit with new Alnylam patent lawsuits over COVID-19 vaccines

reuters.com [1/2] Pfizer company logo is seen at a Pfizer office in Puurs, Belgium, December 2, 2022. REUTERS/Johanna Geron May 26(Reuters) - Biotech company Alnylam Pharmaceuticals Inc…

EU, Pfizer/BioNTech announce amendment to COVID vaccine contract

reuters.com The European Union and drugmakers Pfizer (PFE.N) and BioNTech (22UAy.DE) said on Friday they had reached a deal to amend a COVID-19 vaccine contract, cutting the number the…

Drugmakers Released a Ton of New Cancer Treatment Data. The Biggest Developments

barrons.com A Merck drug that could be a best-in-class treatment for non-small cell lung cancer. An early-stage Pfizer drug that looks like it could compete as a breast cancer…

FDA grants full approval to Pfizer’s Paxlovid

thehill.com The Food and Drug Administration (FDA) on Thursday granted full approval to Pfizer’s COVID-19 oral antiviral pill Paxlovid for use in adults who are at high risk for…

COVID pill Paxlovid gets full FDA approval after over a year of pandemic emergency use

pbs.org Pfizer received full approval on Thursday for its COVID-19 pill Paxlovid that’s been the go-to treatment against the coronavirus. More than 11 million prescriptions for…

Pfizer's COVID antiviral Paxlovid gains full US approval

reuters.com [1/3] Paxlovid, Pfizer's anti-viral medication to treat the coronavirus disease (COVID-19), is displayed in this picture illustration taken October 7, 2022. A morning and an…